Physician profile
Kunal Malik
NPI 1689170615
$49,694.73
in general payments reported to CMS, 2019-2025
21 companies · $46K in 2025
The $46K reported for 2025 was more than what 96% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $996 · 2023: $1,319 · 2024: $905 · 2025: $46K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $30K · Food and Beverage: $18K · Travel and Lodging: $188 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $30,000.00 |
| Food and Beverage | $18,410.75 |
| Travel and Lodging | $187.74 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $30,277.66 | 2024-2025 | |
| Arcutis Biotherapeutics, INC. | $15,061.38 | 2025 | Zoryve |
| Abbvie INC. | $842.79 | 2022-2025 | |
| Janssen Biotech, INC. | $708.12 | 2022-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $529.43 | 2022-2025 | |
| Incyte Corporation | $391.68 | 2022-2025 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $364.21 | 2022-2025 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $230.18 | 2022-2025 | Sotyktu |
| Genzyme Corporation | $219.77 | 2023-2025 | |
| Pfizer INC. | $150.36 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $142.32 | 2023-2025 | Winlevi, Absorica Ld |
| Epi Health, LLC | $135.24 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $123.58 | 2023-2024 | Jublia, Cabtreo, Arazlo |
| Mayne Pharma Commercial LLC | $123.01 | 2023-2025 | |
| Leo Pharma INC. | $96.77 | 2024-2025 | Adbry, Anzupgo |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Journey Medical Corporation | $81.97 | 2023-2025 | |
| Botanix Sb INC | $68.52 | 2025 | Sofdra |
| Lilly USA, LLC | $55.48 | 2024-2025 | Taltz, Ebglyss |
| Dermavant Sciences, INC. | $52.14 | 2023 | Vtama |
| Ucb, INC. | $23.79 | 2022 | |
| Almirall LLC | $16.33 | 2023 | Seysara |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kunal Malik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.